12/10/2024
11:42 AM | Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
12/06/2024
10:44 AM | FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
12/03/2024
6:02 PM | EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
6:02 PM | Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:44 PM | Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
4:45 PM | EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
4:46 PM | Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
|
11/13/2024
4:46 PM | Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
7:06 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
1:47 PM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/04/2024
1:16 PM | VANGUARD GROUP INC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/31/2024
7:59 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
11:50 AM | STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/07/2024
10:37 AM | FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/04/2024
5:01 PM | Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
6:02 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:01 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024
4:06 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
4:07 PM | Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:09 PM | Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:11 PM | Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
5:27 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
5:28 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
6:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
6:16 AM | Zentalis Pharmaceuticals (Filer)
| Form DEFA14A | |
05/29/2024
6:33 AM | Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2024
6:34 AM | Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:46 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:47 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:05 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
3:34 PM | Zentalis Pharmaceuticals (Filer)
| Form DEF 14A | |
04/29/2024
3:36 PM | Zentalis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/11/2024
6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
6:02 AM | Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
3:30 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:14 PM | Zentalis Pharmaceuticals (Filer)
| Form S-3ASR | |
02/29/2024
4:20 PM | Zentalis Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
02/27/2024
6:08 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
6:43 PM | Avidity Partners Management LP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
7:21 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:22 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:23 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
7:25 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
7:25 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:40 AM | WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/05/2024
6:11 PM | Blackwell Kimberly (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:12 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:13 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:14 PM | Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:15 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:16 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:26 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:27 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:28 PM | Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:29 PM | Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:29 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:26 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
6:52 AM | STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
7:19 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2024
7:21 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
4:47 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
